Clinical trials are research studies that test new ways to prevent, detect, or treat diseases. For HIV, clinical trials explore medications, vaccines, prevention strategies, and therapies that could work better than current options or reach people who don't respond well to existing treatments. These aren't experiments—they follow strict scientific and ethical guidelines, and participants are never guinea pigs without informed consent.
Learn About Paying Your FGUA Bill Online →
The journey from laboratory discovery to actual treatment takes years. A potential HIV drug or vaccine goes through several phases of testing. Phase 1 trials focus on safety with a small group. Phase 2 trials measure how well something works and continue monitoring safety. Phase 3 trials compare a new treatment to current standard care with larger groups. Phase 4 trials happen after a drug is approved, tracking long-term outcomes in real-world use.
Why should you know about these trials? They're happening in communities across the country right now. Some trials test new antiretroviral medications that might have fewer side effects. Others explore long-acting injectable treatments that require dosing every two months instead of daily pills. Some focus on prevention for people who are HIV-negative. Others study how to cure or functionally cure HIV—meaning the virus becomes undetectable and nontransmissible, or actually eliminated from the body.
Clinical trials also create opportunities. Participants receive medical monitoring, sometimes get experimental treatments before they're publicly available, and contribute to knowledge that helps millions. The research happening today in these trials directly shapes what treatments will look like in five or ten years.
Practical takeaway: Understanding that clinical trials are structured research—not risky experiments—helps you evaluate whether learning more about a specific trial makes sense for your situation.
Finding trials near you doesn't require complicated detective work, though it does require knowing where to look. The U.S. National Institutes of Health maintains ClinicalTrials.gov, a searchable database of over 400,000 studies worldwide. For HIV specifically, you can search by location, trial phase, and study type. The site shows what each trial is testing, where it's happening, who can participate, and contact information for the research team running it.
Free Guide to Pay by Plate Illinois Billing →
To search ClinicalTrials.gov effectively: Go to the site and enter "HIV" in the condition search. Use the location filter to narrow results to your state or city. You can refine further by filtering for trials that are actively recruiting (meaning they're enrolling new participants right now). The site shows whether trials are studying treatment, prevention, diagnosis, or basic research. Each trial listing includes details about the study design, what participation involves, and how to contact the research site.
Beyond the federal database, many universities and medical centers running HIV research post information on their own websites. Large HIV treatment centers often have research departments that maintain current lists of available trials. If you receive HIV care at a clinic or hospital, ask your doctor or nurse whether they run trials or can refer you to nearby research programs.
Community-based organizations focused on HIV also track clinical trial opportunities. Groups like the AIDS Clinical Trials Group (ACTG) and local community health organizations often maintain lists and can answer questions about what different trials involve. These organizations sometimes host information sessions about specific trials in your area.
Some trials use recruitment specialists who reach out through community networks, support groups, and advocacy organizations. If you're involved in HIV community spaces, you may hear about trials directly from organizers or other participants.
Practical takeaway: Start with ClinicalTrials.gov for a broad view of what's available, then supplement with calls to your local HIV treatment center and community organizations for information about trials you might not find through the database alone.
Not all HIV clinical trials look the same. Understanding what different trials are studying helps you figure out which ones might interest you. Treatment trials test new medications or drug combinations for people living with HIV. These might evaluate whether a new antiretroviral works as well as current standards, or whether it causes fewer side effects. Some treatment trials focus on people whose virus has developed resistance to existing drugs. Others test simplified regimens—like single-pill options or less frequent dosing schedules—for people who are stable on treatment.
Free Guide to Mold Removal Methods for Walls →
Prevention trials study whether new medications or strategies can keep HIV-negative people from becoming infected. PrEP (pre-exposure prophylaxis) trials have tested medications like tenofovir and emtricitabine. Some newer prevention trials explore long-acting injections, vaginal rings, or topical microbicides. Prevention trials recruit people at higher risk of HIV exposure—which might include sexually active gay and bisexual men, transgender people, sex workers, people in serodiscordant relationships (where one partner has HIV and one doesn't), or people who inject drugs.
Cure and remission trials represent the frontier of HIV research. These studies test approaches to either eliminate HIV from the body entirely or create "functional cures" where the virus becomes undetectable without medication. Some use gene therapy. Others combine existing antiretrovirals with immunotherapy drugs designed to wake up dormant HIV and help the immune system clear it. These trials typically involve people with HIV who are willing to undergo more intensive monitoring and sometimes more complex treatment protocols.
Vaccine trials test whether a vaccine can prevent HIV infection or, in therapeutic vaccine trials, help people with HIV control the virus better. HIV vaccine development has been challenging because the virus mutates rapidly, but several promising candidates are in human testing phases.
Diagnostic trials evaluate new testing methods or biomarkers that might detect HIV earlier or predict treatment response. Adherence and behavioral trials study how to support people in staying on treatment or using prevention methods consistently.
Practical takeaway: Knowing the category your potential trial falls into—treatment, prevention, cure research, vaccine development, or diagnostic—helps you understand what commitment and what potential benefits or risks that trial involves.
Clinical trial participation isn't a one-time event. It's an ongoing commitment that varies by study. Before participating, you'll have a screening visit where researchers determine whether you meet the trial's criteria. This involves bloodwork, possibly imaging, health history review, and discussion of what the trial involves. This screening doesn't obligate you to join—it's just information gathering.
How to Delete Your Fitbit Account Guide →
If you decide to participate, the actual involvement depends on the trial. Some require monthly clinic visits. Others require weekly visits during certain phases. Some involve phone check-ins between visits. Treatment trials typically include blood draws to monitor your virus levels, CD4 count, and organ function. Prevention trials often include behavioral assessments and STI testing. Most trials compensate participants for time and travel—not as payment for participating, but as reimbursement for expenses.
Trials have strict protocols about what you can and can't do while participating. You might need to avoid certain medications, limit alcohol, undergo regular testing, and maintain contact with the research team. If the trial is testing a new medication, you follow a specific dosing schedule. Some trials use randomization—meaning you don't choose whether you get the experimental treatment or a standard treatment or placebo; assignment is random. Others use open-label designs where everyone knows what they're receiving.
Data collection is intensive. Researchers need to track what happens to you over time to understand whether the experimental treatment works and what side effects might emerge. This means blood draws, questionnaires about your health and behavior, sometimes imaging studies, and detailed recording of any health changes.
Trials have safety monitoring built in. An independent data and safety monitoring board reviews results as the trial progresses. If a treatment proves clearly effective early, the trial might be stopped so all remaining participants can access the beneficial treatment. If safety concerns emerge, the trial might be paused or stopped.
Your participation is voluntary. You can withdraw from a trial at any time without losing access to your regular medical care. If you're receiving treatment through the trial and you leave, you work with the research team to transition back to standard care safely.
Practical takeaway: Ask about the specific schedule and requirements during your initial screening conversation—knowing exactly what's involved helps you decide whether you can commit to the trial's demands.
When you're considering a particular trial, you need specific information to make an informed decision. Start by understanding the science: What is this trial testing? What makes researchers think it might work? What does existing research show
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.